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A recombinant vesicular stomatitis virus (VSV-PeGFP-M-MmRFP) encoding enhanced green fluorescent
protein fused in frame with P (PeGFP) in place of P and a fusion matrix protein (monomeric red fluorescent
protein fused in frame at the carboxy terminus of M [MmRFP]) at the G-L gene junction, in addition to
wild-type (wt) M protein in its normal location, was recovered, but the MmRFP was not incorporated into the
virions. Subsequently, we generated recombinant viruses (VSV-PeGFP-⌬M-Mtc and VSV-⌬M-Mtc) encoding
M protein with a carboxy-terminal tetracysteine tag (Mtc) in place of the M protein. These recombinant viruses
incorporated Mtc at levels similar to M in wt VSV, demonstrating recovery of infectious rhabdoviruses
encoding and incorporating a tagged M protein. Virions released from cells infected with VSV-PeGFP-⌬M-Mtc
and labeled with the biarsenical red dye (ReAsH) were dually fluorescent, fluorescing green due to incorporation of PeGFP in the nucleocapsids and red due to incorporation of ReAsH-labeled Mtc in the viral envelope.
Transport and subsequent association of M protein with the plasma membrane were shown to be independent
of microtubules. Sequential labeling of VSV-⌬M-Mtc-infected cells with the biarsenical dyes ReAsH and FlAsH
(green) revealed that newly synthesized M protein reaches the plasma membrane in less than 30 min and
continues to accumulate there for up to 2 1/2 hours. Using dually fluorescent VSV, we determined that following
adsorption at the plasma membrane, the time taken by one-half of the virus particles to enter cells and to
uncoat their nucleocapsids in the cytoplasm is approximately 28 min.
proteins or to label viral membranes with lipophilic dyes, have
allowed studies of the dynamic events of virus entry as well as of
virus-cell interactions (17, 27–29, 31, 34, 40, 43, 51, 53). For enveloped viruses, the hallmark event of infection is the fusion of
the viral envelope and the release of the NC (or RNP) into the
cytoplasm. To examine the infection process by fluorescence microscopy and to distinguish between the enveloped virion and the
uncoated NC, it is essential to differentially label the viral envelope and the NC core. Dually fluorescent viruses in which the viral
core component, such as the NC or the RNP, is labeled with one
fluorescent color and the envelope component is labeled with
another color are thus powerful reagents for studies of virus entry
and NC uncoating during early stages of infection as well as for
studies of virus assembly during late stages of infection. Recently,
dually fluorescent rabies virus (27) and human immunodeficiency
virus (HIV) (9, 30) have been generated successfully. Using the
dually fluorescent rabies virus, it was demonstrated that complete
virus particles are transported in a retrograde manner (27).
Successful recovery of a recombinant VSV encoding the P
protein fused in frame with enhanced green fluorescent protein (PeGFP) allowed us to track the intracellular transport of
viral NCs by live-cell imaging (14). This study demonstrated
that microtubules were involved in viral NC transport toward
the cell periphery (14), presumably to the plasma membrane
for virus assembly. Whether the M protein interacts with the
viral NCs before transport to the plasma membrane or at the
plasma membrane prior to virus assembly remains a fundamental question in VSV assembly. Previous studies have shown
that the M protein and the NCs do interact in vitro and in vivo
(11, 12, 26), although more recent studies suggest that such

Vesicular stomatitis virus (VSV), the prototypic rhabdovirus
within the family Rhabdoviridae and the order Mononegavirales, is an enveloped virus with a negative-stranded RNA
genome of 11,161 nucleotides. The viral genome encodes five
proteins, namely, the nucleoprotein (N), the phosphoprotein
(P), the matrix protein (M), the glycoprotein (G), and the large
polymerase protein (L) (35). The genome is present within the
virion core as a ribonucleoprotein (RNP) or nucleocapsid
(NC) complex tightly encapsidated by the N protein and associated with the viral RNA-dependent RNA polymerase, a multiprotein complex of the viral L and P proteins. The G protein
forms spikes on the viral envelope, binds to cell surface receptors, and plays a role in entry of virus into susceptible cells. The
M protein is multifunctional; it plays a role in virus assembly
and is responsible for cytopathogenesis observed in virus-infected cells (6).
Studies on viral protein transport and virus motility in infected
cells have been facilitated by imaging of fluorescent proteins
fused to viral structural proteins (for reviews, see references 8 and
23). Recent advances in imaging techniques, coupled with the
ability to genetically tag viral structural proteins with fluorescent
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interactions may occur only at the plasma membrane (18, 54).
To examine the events of virus entry, uncoating, and also
assembly, we wanted to generate a dually fluorescent VSV
encoding PeGFP and monomeric red fluorescent protein fused
in frame with the M protein at its carboxy terminus (MmRFP).
Although repeated attempts to recover VSV with the fluorescently tagged M protein in place of wild-type (wt) M were
unsuccessful, viruses encoding the fluorescently tagged M protein could be recovered when it was inserted as an extra cistron
at the G-L gene junction. Further use of this virus for studies
of virus entry, uncoating, and egress was limited because the
MmRFP fusion protein was not incorporated into the virions.
Recently, a new method of genetic tagging of proteins for
fluorescence imaging was developed wherein the protein is
tagged with a relatively smaller tetracysteine (tc) motif
(CCPGCC). This motif can be recognized specifically by membrane-permeable biarsenical dyes that fluoresce when covalently bound to the cysteine pairs in the tc motif (1, 24, 39).
Such a small tag can be fused to the protein of interest with
minimal disruption of protein function. This is a powerful
approach for real-time visualization of nascent protein synthesis and trafficking, as the existing and newly synthesized pools
of proteins can be labeled differentially with the two fluorescent biarsenical dyes, FlAsH (green) and ReAsH (red) (38,
48). Using a tc-tagged M protein (Mtc) encoded in place of the
wt M protein in the VSV genome, we rescued recombinant
viruses (VSV-PeGFP-⌬M-Mtc and VSV-⌬M-Mtc) and demonstrated that the Mtc was incorporated into infectious virions
in amounts similar to that observed for M protein in wt VSV.
Moreover, dynamic imaging of newly synthesized M protein by
sequential labeling with the two biarsenical dyes revealed that
the M protein is transported from the site of synthesis inside
the cytoplasm to the plasma membrane in less than 30 min. We
have also shown that the M protein reaches the plasma membrane independent of NCs and the microtubules. Additionally,
our results show that following adsorption, entry and uncoating
of VSV in the infected cells occur with a half-life of approximately 28 min.
MATERIALS AND METHODS
Cell culture, viruses, antibodies, and reagents. Baby hamster kidney (BHK21) cells were grown and maintained as described before (16). Stocks of vaccinia
virus vTF7-3 (19) were prepared and titrated in BHK-21 cells as described
previously (25). VSV (Indiana serotype) was grown and titrated in BHK-21 cells.
Mouse anti-VSV antibody has been described previously (15). Anti-M monoclonal antibody (MAb)-producing 23H12 hybridoma cells were kindly provided by
Douglas Lyles (32). Supernatant from the hybridoma culture was used as the
source of MAb. Secondary antibodies were obtained from Molecular Probes.
The biarsenical dyes, ReAsH and FlAsH, were obtained from Invitrogen. Nocodazole (NOC), colcemid, and cycloheximide were obtained from Sigma-Aldrich and were used at concentrations of 10 g/ml, 10 g/ml, and 100 g/ml of
growth medium, respectively.
Plasmid construction, transfection, and virus recovery. The plasmid
pGEM-M encodes wt M protein of VSV under the control of the T7 RNA
polymerase promoter. The coding region of mRFP was amplified from the
plasmid pRSET-mRFP, kindly provided by Roger Tsien (10), using primers
RFPBamSnF and RFPBsiSphR (Table 1), and cloned into pGEM-3 vector
under the control of the T7 RNA polymerase promoter, resulting in the plasmid
pGEM-mRFP. The pGEM-MmRFP and pGEM-mRFPM plasmids encode
MmRFP and mRFPM fusion proteins, with mRFP fused in frame at the carboxy
and amino termini of the M protein, respectively. To construct the pGEMMmRFP plasmid, a two-step PCR procedure was used. The sequences of the
primers used to construct these fusion proteins are shown in Table 1. In the first
PCR, a forward primer (MBamSnF) containing the ATG start codon and the
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TABLE 1. Primers used in this study
Primer

Nucleotide sequence (5⬘–3⬘)a

VSVXbaI2070F...................................ATATATCTCATCTAGAGGA
GAGTTCATCT
VSVSnaBI2240R ................................CTTTAAGGAACTCATGGTA
CGTAGATTGGGATAACAC
VSVMEco47III2378R........................ATATATGGAGCGCTCGGAG
CATACTCCATGCT
VSVGMluIR .......................................GCACTTCATAGTGACGCGT
AAACAGATCGATCTCT
VSVMEco47IIIF ................................GAGTATGCTCCGAGCGCTC
CAATTGACA
VSVMBsiWI2943R ............................GTTCAGAAGCTAGAAGTCG
TACGAGCTCATTTGAA
GTGG
MBamSnF............................................ATATATGGATCCTACGTACC
ATGAGTTCCTTAAAG
RFPBamSnF........................................ATATATGGATCCTACGTACC
ATGGCCTCCTCCG
MBsiSphR............................................ATATATGCATGCCGTACGAG
CTCATTTGAAGTGGCTG
ATAG
RFPBsiSphR .......................................ATATATGCATGCCGTACGTT
AGGCGCCGGTGGAGTG
M-RFPF...............................................GATTCTATCAGCCACTTCA
AAATGGCCTCCTCCGAG
GACGTC
M-RFPR ..............................................GACGTCCTCGGAGGAGGC
CATTTTGAAGTGGCTGAT
AGAATC
RFP-MF...............................................CGCCACTCCACCGGCGCCA
TGAGTTCCTTAAAGAAG
RFP-MR ..............................................CTTCTTTAAGGAACTCATG
GCGCCGGTGGAGTGGCG
MBamBsiF...........................................ATATATGGATCCCGTACGGC
CGCCACCATGAGTTCCTT
AAAG
MtcBsiSphR.........................................ATATATGCATGCCGTACGCT
Acggttccatgcaacatccgggacaaca
gttgaggaa TTTGAAGTGGCT
GATAGAATC
a
Restriction enzyme sites are shown in bold. Sequences corresponding to the
tc tag are shown with lowercase letters.

downstream 12 nucleotides from the 5⬘ coding region of VSV M protein and a
reverse primer (M-RFPR) containing the 3⬘ end of the M coding region and the
5⬘ end of the mRFP coding region were used to amplify the entire M coding
region. Another PCR was performed with a forward primer (M-RFPF) comprising the 3⬘ end of the M coding region and the 5⬘ end of the mRFP coding region
and a reverse primer (RFPBsiSphR) containing the 3⬘ end of the mRFP coding
region to amplify the entire mRFP coding region. In the second-round PCR,
which combined the M and mRFP coding regions, the above two PCR products
were annealed together and amplified by PCR, using the MBamSnF and RFPBsiSphR primers. The PCR product was digested with BamHI and SphI and
cloned into pGEM vector that had been digested with the same enzymes. The
plasmid pGEM-mRFPM was also generated using a similar PCR approach, with
the primers RFPBamSnF, RFP-MR, RFP-MF, and MBsiSphR, described in
Table 1. To construct the plasmid coding for the M protein fused with a tc motif
at the carboxy-terminal end, the forward primer MBamSnF was used in conjunction with a reverse primer (MtcBsiSphR) constituting the 3⬘ end of the M
coding sequence and the coding region of the tc tag (FLNCCPGCCMEP) (39).
The PCR product was then digested with BamHI and SphI and cloned into
pGEM vector, and the plasmid was designated pGEM-Mtc. The coding regions
of MmRFP, mRFPM, and Mtc in the constructs were checked for accuracy by
nucleotide sequencing of the clones.
To insert the coding region for the MmRFP fusion protein as an extra cistron
at the G-L gene junction in the full-length VSV genome, the plasmid FLVSVBsiWI
(14) was used. The MmRFP region was PCR amplified from the plasmid pGEMMmRFP, using primers MBamBsiF and RFPBsiSphR (Table 1), digested with
the enzyme BsiWI, and cloned into plasmid FLVSVBsiWI that had been digested

VOL. 83, 2009

DUALLY FLUORESCENT VSV FOR STUDIES ON VIRUS UNCOATING

with the same enzyme. The resulting plasmid was designated pVSV-M-MmRFP.
A full-length genome plasmid encoding both PeGFP and MmRFP was then
generated by fragment exchanges between plasmids pVSV-MmRFP and pVSVPeGFP, using the restriction enzymes BstZ17I and MluI, and the resulting
plasmid was designated plasmid pVSV-PeGFP-M-MmRFP.
To introduce the MmRFP or Mtc coding sequence into the full-length VSV
genome in place of the wt M gene, two unique restriction sites were engineered,
one (SnaBI) before the start codon and the other (BsiWI) after the stop codon
of the M gene in the plasmid pVSV-PeGFP (14), using the megaprimer method
(52) of PCR, to give rise to the plasmid pVSV-PeGFPSB. For insertion of the
SnaBI site at the 5⬘ noncoding region of the M gene, a PCR was performed using
a forward primer (VSVXbaI2070F) spanning the XbaI site, located in the P
gene, in combination with a reverse primer (VSVSnaBI2240R) containing the
SnaBI site, which had been placed upstream of the ATG start codon of the M
gene. This PCR product was used as a megaprimer for another round of PCR
with a reverse primer (VSVMEco47III2378R) spanning the Eco47III site, located inside the M coding region. For both PCRs, plasmid pVSV-PeGFP was
used as the DNA template. The final PCR product was then digested with the
enzymes XbaI and Eco47III and cloned into pVSV-PeGFP plasmid that had
been digested with the same enzymes. The resulting plasmid, which contained
the SnaBI site, was designated pVSV-PeGFPSnaBI. To insert the BsiWI site at the
3⬘ noncoding region of the M gene, a forward primer (VSVMEco47IIIF) spanning the Eco47III site and a reverse primer (VSVMBsiWI2943R) containing a
BsiWI site placed downstream of the stop codon of the M gene were used to
generate a megaprimer, using plasmid pVSV-PeGFP as the template. For the
second round of PCR, the megaprimer was used in conjunction with a reverse
primer (VSVGMluIR) spanning the MluI site, located at the 5⬘ noncoding
region of the G gene, with plasmid pVSV-PeGFP as the template. The second
PCR product was digested with the enzymes Eco47III and MluI and replaced in
the corresponding region of plasmid pVSV-PeGFPSnaBI that had been digested
with the same enzymes, resulting in the plasmid pVSV-PeGFPSB. These two
restriction sites were also inserted in the corresponding region of plasmid
pFLVSV to give rise to plasmid pFLVSVSB. The plasmid pVSV-PeGFPSB was
then used to replace the coding sequence of the wt M protein with that of either
MmRFP or Mtc to give rise to the plasmid pVSV-PeGFP-⌬M-MmRFP or
pVSV-PeGFP-⌬M-Mtc, respectively. The MmRFP or Mtc coding region was
also inserted into plasmid pFLVSVSB in place of wt M, resulting in the plasmid
pVSV-⌬M-MmRFP or pVSV-⌬M-Mtc, respectively. All clones were sequenced
to ensure that only plasmids with the correct coding sequences were used for
further studies. Virus recovery and identification of recovered viruses were performed as described previously (15). The recovered viruses were designated
VSV-⌬M-Mtc and VSV-PeGFP-⌬M-Mtc and encoded Mtc in place of M.
Metabolic labeling and analysis of proteins in transfected and infected cells.
Metabolic labeling of proteins in transfected or virus-infected cells or of proteins
in virions, immunoprecipitation using anti-VSV antibody (1:100) or anti-M antibody (1:100), sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE), and detection of proteins by fluorography were carried out as described
previously (15). Proteins incorporated into extracellular virions were examined
by radiolabeling as described previously (14).
Determination of single-step growth kinetics. Single-step growth kinetics of wt
and mutant viruses in BHK-21 cells were determined as described previously
(15).
Biarsenical labeling of transfected or virus-infected cells. Biarsenical labeling
with FlAsH and ReAsH was performed per the manufacturer’s recommendations provided in the tc tag detection kit (Invitrogen). Briefly, BHK-21 cells were
grown on glass coverslips in 12-well cell culture plates. At 4 h postinfection (hpi)
or posttransfection (hpt), cells were washed once with Opti-MEM (Invitrogen)
and labeled with ReAsH dye (1.25 M to 2.5 M) in 400 l of Opti-MEM for
30 min at room temperature. Supernatant was then discarded, and cells were
washed in BAL (2,3-dimercapto-1-propanol) wash buffer (supplied in the kit;
Invitrogen) in Hanks’ balanced salt solution three times at room temperature.
Subsequently, the cells were fixed in 4% paraformaldehyde and processed for
staining with anti-M antibody as described previously (14). For dual biarsenical
labeling, cells infected with VSV-Mtc or transfected with pGEM-Mtc were
treated with ReAsH for 30 min at 3 hpi or 4 hpt, respectively, as described above.
Supernatant was discarded, and cells were washed in BAL wash buffer and either
labeled immediately with the second biarsenical dye, FlAsH (1.25 M to 2.5
M), in Opti-MEM or incubated at 37°C in complete growth medium for 1 or 2 h
before FlAsH labeling. For the later time period analyses, cells were again rinsed
with Opti-MEM and labeled with FlAsH (1.25 M to 2.5 M) for 30 min at room
temperature. After FlAsH labeling, cells were washed thoroughly in BAL wash
buffer in Hanks’ balanced salt solution as described above and processed for
staining with anti-M antibody. Cells were then visualized under an inverted
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confocal microscope. For ReAsH labeling of extracellular virus particles, infected cells at 4 hpi were treated with ReAsH as described above for 12 h. The
culture supernatant containing the dye-labeled virus was collected and clarified.
The virus particles were purified by sucrose density gradient centrifugation and
used for further studies.
Fluorescence microscopy. For epifluorescence and differential interference
contrast microscopy, BHK-21 cells were grown in 35-mm culture dishes, with or
without glass coverslips, and were either fixed with 4% paraformaldehyde or
visualized directly under an Olympus FV500/IX81 inverted laser scanning confocal microscope as described previously (14). Immunofluorescence staining was
performed with anti-M MAb (1:100) as described previously (14). For measurement of fluorescence intensities of virus particles, images of particles were collected with an Olympus FV500 confocal laser scanning microscope, using a
dual-laser line and sequential image collection program (488-nm excitation and
522-nm emission for GFP; 565-nm excitation and 595-nm emission for ReAsH)
with the same confocal settings for laser power, gain, photomultiplier tube, and
offset levels. The mean fluorescence intensities of viral particles were obtained
with the same defined threshold and intensity measurement for green and red
panels, using AnalySIS-Opti image analysis software (Soft Imaging System Co.,
Lakewood, CO). The relative fluorescence intensities were calculated with the
green fluorescence intensity set arbitrarily at 100. For measurement of the
relative levels of ReAsH-labeled Mtc on the membranes of cells treated with or
without NOC, fluorescence intensities on the membrane regions of the cells
infected with VSV-PeGFP-⌬M-Mtc were quantitated using the software FV500,
version 4.3, with an FV500/IX81 inverted confocal microscope (Olympus).
Twelve randomly selected membrane areas of equal size were chosen per cell,
and eight cells from each of the two independent experiments, treated with or
without the drug, were used for data collection. Total fluorescence intensities
were determined in arbitrary units and analyzed statistically as described below.
Statistical analysis. Differences in total fluorescence intensity on membranes
in BHK-21 cells after VSV-PeGFP-⌬M-Mtc virus infection for drug-treated and
untreated groups were analyzed by the t test, using SAS software, version 9.1
(SAS Institute Inc., Cary, NC). P values of ⬎0.05 were considered insignificant.

RESULTS
Dually fluorescent VSV expressing PeGFP and MmRFP fusion proteins. Previously, we reported the recovery of a fluorescent virus (VSV-PeGFP) encoding PeGFP, a fusion protein
with EGFP inserted in frame within the P protein (14). In the
present study, we attempted to generate a dually fluorescent
recombinant VSV encoding mRFP fused in frame with the
matrix protein (M) in the genomic background of VSVPeGFP. The use of such a dually fluorescent VSV will be
invaluable in examining virus uncoating during the initial
stages of the infection cycle and virus assembly at the late
stages of infection. To generate the dually fluorescent VSV, we
first constructed a fusion protein (MmRFP) in which the entire
coding region of mRFP was fused in frame at the carboxy
terminus of the M protein. In cells transfected with the plasmid
encoding MmRFP, the fusion protein was expressed with the
predicted molecular mass of ⬃65 kDa (Fig. 1A), at levels
similar to that of the M protein, and was also found to be as
stable as the M protein (data not shown). Unlike mRFP, which
was localized in the cytoplasm (Fig. 1B, lower right panel), the
MmRFP fusion protein was found to be associated with the
plasma membrane (Fig. 1B, upper panels) in a pattern that is
typical of the M protein (Fig. 1B, lower left panel) (12).
Several attempts to recover viruses encoding MmRFP in
place of wt M were unsuccessful, perhaps indicating that the
MmRFP fusion protein is not competent to support infectious
virus assembly and budding. Subsequently, plasmids carrying
recombinant VSV genomes constructed by inserting the
MmRFP coding sequence between the G-L gene junction in
the wt VSV or VSV-PeGFP genome (Fig. 1C) led to recovery
of the recombinant viruses (VSV-M-MmRFP and VSV-
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FIG. 1. Recovery and characterization of recombinant VSV encoding fluorescent fusion proteins. (A) Expression of M and MmRFP
fusion proteins. BHK-21 cells infected with vTF7-3 and transfected with a plasmid encoding M (lane 1) or MmRFP (lane 2) were
radiolabeled with Expre35S35S label for 2 h at 16 hpt. The radiolabeled proteins were immunoprecipitated with anti-VSV antibody, separated
by SDS-PAGE, and detected by fluorography. Size markers in kDa are shown on the left. The M and MmRFP proteins are identified with
arrows on the right. (B) Epifluorescence and immunofluorescence staining of cells expressing the MmRFP, M, or mRFP protein. (C) Recombinant VSV genome plasmids. VSVwt, the wt VSV genome, with the N, P, M, G, and L genes shown in rectangular boxes; VSV-PeGFP,
genome encoding PeGFP in place of wt P; VSV-M-MmRFP, genome encoding MmRFP at the G-L gene junction; VSV-PeGFP-M-MmRFP,
genome encoding MmRFP at the G-L gene junction of the VSV-PeGFP genome. Intergenic regions as well as 3⬘-leader-gene and 5⬘-trailer
sequences are shown in black boxes. (D) Growth of recombinant viruses. BHK-21 cells were infected with various recombinant VSVs at an
MOI of 5. Growth of each recombinant virus was determined by plaque assay of culture supernatants at 16 hpi. Virus titers shown are
averages from three independent experiments, with the standard deviations indicated by error bars. (E) Analysis of viral proteins in cells
infected with recombinant VSVs. BHK-21 cells were infected with wt VSV (lanes 2 and 7), VSV-PeGFP (lanes 3 and 8), VSV-M-MmRFP
(lanes 4 and 9), or VSV-PeGFP-M-MmRFP (lanes 5 and 10) at an MOI of 10 or were left uninfected (lanes 1 and 6). The proteins were
radiolabeled for 1 h at 4 hpi, immunoprecipitated with anti-VSV antibody (lanes 1 to 5) or with anti-M antibody (lanes 6 to 10), separated
by SDS-PAGE, and detected by fluorography. The viral proteins along with the fusion proteins are identified in the middle. (F) Examination
of proteins incorporated into extracellular virions. The viral proteins in cells infected with VSV or VSV-PeGFP-M-MmRFP were radiolabeled with Expre35S35S label for 12 h at 4 hpi, and the proteins incorporated into the purified virions (VSV, lanes 1 and 3; and
VSV-PeGFP-M-MmRFP, lanes 2 and 4) were examined by immunoprecipitation with anti-VSV antibody (lanes 1 and 2) or as total proteins
(lanes 3 and 4). The positions of the viral proteins are shown on the right.

PeGFP-M-MmRFP). Examination of single-step and multistep growth kinetics revealed no apparent differences between
the viruses (data not shown), although the overall yields of the
viruses were lower than that of wt VSV (Fig. 1D). The VSVPeGFP-M-MmRFP virus grew to a final titer that was 25- to

50-fold less than that of wt VSV, whereas the VSV-M-MmRFP
titer was about 10-fold less than that of wt VSV. Examination
of the viral proteins synthesized in cells infected with these
recombinant viruses suggested that both PeGFP and MmRFP
fusion proteins of predicted molecular masses were detected in
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appropriate recombinant VSV-infected cells (Fig. 1E). In most
cells infected with VSV-PeGFP-M-MmRFP, both green and
red fluorescence was readily observed, and these cells appeared yellow when observed simultaneously under both laser
lights (data not shown). However, a small number of patches of
cells infected with VSV-PeGFP-M-MmRFP appeared exclusively green or red (data not shown). Further examination
indicated that these cells were infected with viruses that expressed only green or red fluorescence. On average, the greenor red-only viruses represented ⬍3% of the total virus population. The molecular basis of the phenotype of these viruses is
currently being examined and will be reported elsewhere.
MmRFP fusion protein is not incorporated into VSVPeGFP-M-MmRFP virions. Since our goal is to use dually
fluorescent viruses for studies of virus entry, NC uncoating,
assembly, and egress, we wanted to determine whether both
PeGFP and MmRFP fusion proteins were incorporated into
extracellular virions. Accordingly, radiolabeled virions from
the supernatants of cells infected with VSV-PeGFP-MMmRFP were concentrated by ultracentrifugation, and the
viral proteins were analyzed for the presence of the two fluorescent fusion proteins by electrophoretic analyses. Although
the PeGFP fusion protein could readily be detected in the
virions, the MmRFP fusion protein was not detectable by examining the immunoprecipitated or total proteins from the
virions (Fig. 1F, lanes 2 and 4). Repeated experiments with
increasing amounts of total viral proteins from purified virions
failed to demonstrate the presence of MmRFP. Similar studies
with mRFPM fusion protein also failed to demonstrate incorporation of the fusion protein into the extracellular virions
(data not shown). These results indicate that the MmRFP or
mRFPM fusion protein is not competent to be incorporated
into virions.
Mtc supports assembly of infectious VSV and is incorporated into virions. We rationalized that the inability of
MmRFP to be incorporated into virions might be due to its
increased size or the fact that it is not competent to support
virus assembly. To address the potential size constraint, we
examined if a smaller tag could be used at the carboxy terminus
of the M protein to generate the recombinant virus. tc motifs
usually form hairpin structures and bind specifically to biarsenical dyes through covalent interactions, causing fluorescence and allowing live imaging of cells expressing the tctagged proteins (24). Depending on the biarsenical dyes used,
the proteins can be visualized as either green (labeled with
FlAsH) or red (labeled with ReAsH) under a fluorescence
microscope. To examine if a tc motif could be fused with M
protein without adversely affecting its functions, we fused a tc
motif of 12 amino acids (FLNCCPGCCMEP) (39) at the carboxy terminus of the M protein. Mtc was expressed in transfected cells (Fig. 2A) and was associated with the plasma membrane (Fig. 2B, panel d) in a manner similar to that of the wt
M protein (Fig. 2B, panel a), as judged by immunofluorescence
staining of the transfected cells. To examine if the Mtc protein
could be labeled specifically with ReAsH, cells transfected with
the plasmid encoding Mtc were incubated with the biarsenical
dye for 30 min at 4 hpt. Under a fluorescence microscope, Mtc
(red fluorescence) was seen to be distributed throughout the
cytoplasm and also localized to the plasma membrane (Fig. 2B,
panel e). Immunofluorescence staining of the ReAsH-labeled
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FIG. 2. Expression of Mtc fusion protein in transfected cells.
(A) Cells transfected with a plasmid encoding M (lane 2) or Mtc (lane
3) protein or mock-transfected cells (lane 1) were radiolabeled with
Expre35S35S label for 2 h at 16 hpt. The radiolabeled proteins were
immunoprecipitated with anti-VSV antibody, analyzed by SDS-PAGE,
and detected by fluorography. Size markers in kDa are shown on the
left. The M and Mtc proteins are identified on the right. (B) Biarsenical dye ReAsH labeling of cells expressing the M (a, b, and c) or the
Mtc (d, e, and f) protein. Transfected cells were treated with ReAsH
as described in Materials and Methods. Following washing of the dye,
the cells were fixed and subjected to immunofluorescence staining with
anti-M antibody and anti-mouse Alexa 488-conjugated secondary antibody. ReAsH staining (b and e), anti-M staining (a and d), and
merged images of staining of the same cells (c and f) are shown.

cells with anti-M MAb showed the localization of the Mtc (Fig.
2B, panel d) in these transfected cells. The merged image (Fig.
2B, panel f) showed that the two signals (red and green) overlapped, demonstrating that the ReAsH dye specifically labeled
the Mtc protein. Additionally, because of the close overlap of
the ReAsH staining and immunostaining with anti-M antibody
(Fig. 2B, panel f), it appears that similar pools of M proteins
are detected by the two methods. A low level of nonspecific
background staining with ReAsH was observed in the nuclei of
cells transfected with the wt M protein (Fig. 2B, panel b),
which could easily be distinguished from the authentic M signal by anti-M staining (Fig. 2B, panel a). This type of nonspecific staining with ReAsH has also been observed by others
(48). Incubation of cells with ReAsH did not have any adverse
effect on the localization of M or on the morphology of the
treated cells. These data indicate that biarsenical labeling of tc
tags can authentically detect M inside cells. Overall, the results
demonstrate that wt M and Mtc localize to the same membranous areas in the cell, indicating that the tc tag does not affect
the membrane localization properties of the protein.
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FIG. 3. Recovery of VSV encoding Mtc. (A) Genome organization of wt VSV, VSV-PeGFP, and VSV-PeGFP-⌬M-Mtc. (B) Single-step growth
kinetics of recombinant viruses. Virus titers shown are averages from three independent experiments, with the standard deviations indicated by
error bars. (C) Analysis of viral proteins in cells infected with recombinant VSVs. BHK-21 cells were mock infected (lane 1) or infected with wt
VSV (lane 2), VSV-PeGFP (lane 3), or VSV-PeGFP-⌬M-Mtc (lane 4) at an MOI of 10. The proteins were radiolabeled for 1 h at 4 hpi,
immunoprecipitated with anti-VSV antibody, separated by SDS-PAGE, and detected by fluorography. The viral proteins along with the fusion
proteins are identified on the right. (D) Examination of proteins incorporated into purified virions. Viral proteins in cells infected with VSV,
VSV-PeGFP, or VSV-PeGFP-⌬M-Mtc were radiolabeled as described in the legend to Fig. 1F, and the proteins incorporated into purified virions
(VSV, lane 1; VSV-PeGFP, lane 2; and VSV-PeGFP-⌬M-Mtc, lane 3) were examined. The positions of various proteins are shown on the right.

In order to recover a recombinant VSV that could express
and incorporate both Mtc and PeGFP fusion proteins, we
constructed the plasmid VSV-PeGFP-⌬M-Mtc by replacing
the coding region of M with that of Mtc in the plasmid VSVPeGFP (Fig. 3A) and subsequently recovered the virus. Cytopathic effects specific for VSV were observed in infected cells,
which also exhibited green fluorescence due to the expression
of the PeGFP fusion protein. However, the cytopathic effects
in these cells were less pronounced than those observed for
VSV-PeGFP or wt VSV, indicating that the recovered virus
might be less cytopathic (data not shown). VSV-PeGFP-⌬MMtc grew at a lower rate than VSVwt and VSV-PeGFP did,
with a maximum titer of approximately 2 ⫻ 108 PFU/ml (Fig.
3B). Analysis of viral proteins in infected cells showed expression of Mtc with a slightly slower electrophoretic mobility consistent in size with the fusion of the tc tag with M (Fig. 3C). In
addition, the Mtc protein of correct size was incorporated into
virions at levels similar to that of wt M (Fig. 3D). These results
demonstrate that Mtc is competent to support VSV assembly
and is incorporated into infectious VSV particles.
Biarsenical labeling with ReAsH allows detection of dually
fluorescent virions. In order to produce dually fluorescent
VSV particles, we incubated VSV-PeGFP-⌬M-Mtc-infected
cells at 4 hpi with ReAsH for 12 h. Labeled virus particles

present in the clarified culture supernatant were placed on a
microscope slide and examined under a confocal laser scanning
fluorescence microscope. Double-labeled particles with perfect
colocalization of EGFP and ReAsH fluorescence were readily
detectable (Fig. 4A and B) as yellow particles (Fig. 4C), indicating that both the fusion proteins were incorporated into the
virions. We determined the relative fluorescence intensities of
50 individual dually fluorescent virus particles and found that
the relative red fluorescence intensities of the particles were,
on average, about 85% of the green fluorescence intensities
(Fig. 4D). However, some of the particles (as an example, the
one identified by the white arrows in the panels) possessed a
green fluorescence intensity considerably lower than the average intensity displayed by most particles. In addition, a small
number of particles (⬍5%) with either green or red fluorescence were also detected (data not shown). The red-only particles were, on average, smaller in size than the yellow or
green-only particles and could potentially represent empty
membrane vesicles containing Mtc, whereas the green-only
signals could be due to uneven labeling of the particles with
ReAsH.
Plasma membrane localization of M protein is not affected
by inhibitors of microtubule polymerization. We had previously shown that in cells infected with VSV, newly synthesized
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FIG. 4. VSV-PeGFP-Mtc virions exhibit dual fluorescence. Cells
infected with VSV-PeGFP-⌬M-Mtc were treated with ReAsH for 12 h
at 4 hpi. Samples (1 to 2 l) of the clarified culture supernatant were
placed on glass coverslips and visualized under an inverted microscope.
High-resolution images of the viral particles were collected sequentially, using a 488-nm laser line for eGFP (A) and a 596-nm laser line
for ReAsH (B), and then displayed using the simultaneous dual-channel mode (C). Arrows in the panels show one virus particle with a
significantly reduced eGFP signal compared to those of the other
particles. (D) Quantitation of fluorescence intensities of a total of 50
dually fluorescent particles. Histograms show average relative intensities for green and red fluorescence, with the error bar showing the
standard deviation.

NCs are transported from the sites of synthesis to the cell
periphery by a microtubule-dependent mechanism (14). The M
protein, synthesized in the cytoplasm, is also localized to the
plasma membrane for virus assembly. The mechanism by
which the M protein is localized to the plasma membrane is not
known. It was previously shown that the VSV M protein physically associates with tubulin (42). Therefore, we rationalized
that the M protein distribution in the cytoplasm as well as its
membrane association may be mediated by microtubules. To
examine if microtubules have any effect on the intracellular
distribution or plasma membrane localization of M protein in
virus-infected cells, we pretreated the cells with NOC, a drug
known to inhibit microtubule polymerization. Under these
conditions, complete depolymerization of microtubules has
been observed (14). Subsequently, the cells were infected with
VSV-PeGFP-⌬M-Mtc. At 4 hpi, the infected cells were treated
with ReAsH for 30 min to label the Mtc protein. The cells were
washed, fixed, and then observed under a fluorescence microscope. The Mtc protein (stained red) was seen to be localized
to the plasma membranes of cells that were treated with NOC
(Fig. 5E), in a manner similar to that in cells not treated with
the drug (Fig. 5B). On the other hand, the distribution of viral
NCs was significantly altered in the presence of the drug (Fig.
5D), as we demonstrated previously (14). We then quantitated
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the accumulation of the Mtc protein in the membranes of both
NOC-treated and untreated cells, using the software FV500
that was provided with the confocal microscopy system. Our
data show that there was no statistically significant difference in
the membrane accumulation of Mtc protein in both drugtreated and untreated cells (Fig. 5G). Colcemid, another drug
that is known to inhibit microtubule polymerization, also did
not have any effect on M protein distribution (data not shown).
Together, these results indicate that microtubules do not play
any role in intracellular distribution or plasma membrane localization of the M protein. Previous studies have shown that
the M protein associates with NCs, both in vitro and in vivo
(11, 12, 26), albeit with a low affinity (18). However, a recent
study showed no direct colocalization of M and the NCs in the
cytoplasm or at sites on the plasma membrane other than virus
budding sites (54). Our data shown in Fig. 5 clearly reveal a
lack of colocalization of the M protein with the viral NCs in the
cytoplasm or at the plasma membrane, thus confirming the
results of the recent study (54).
Dynamic imaging of newly synthesized and existing pools of
M protein in virus-infected cells by dual biarsenical labeling.
To study the dynamics and destination of newly synthesized M
protein, we employed the procedure of dual biarsenical labeling. Currently, biarsenical labeling is the only available method
to visualize newly synthesized proteins by imaging (20, 38, 46,
48). With this method, one biarsenical dye is used to label the
existing pool (steady-state level) of protein. Once the existing
pool of proteins is labeled, the unbound dye is washed out of
the cells and the other dye is added to the cells to label the
newly synthesized proteins. Since the dye binding is irreversible, the existing pool of proteins is labeled with one dye and
the newly synthesized pool of proteins is labeled with the other
dye, and both pools of proteins can be visualized simultaneously by live- or fixed-cell imaging.
To examine the existing pool of M proteins as well as the
pool of newly synthesized proteins in VSV-infected cells, we
first recovered a recombinant VSV (VSV-⌬M-Mtc) encoding
the Mtc protein in place of the wt M protein, which grew to
titers similar to those of wt VSV (data not shown). BHK-21
cells were then infected with VSV-⌬M-Mtc. At 4 hpi, cells
were labeled with ReAsH for 30 min. Following washing away
of the dye, the cells were exposed immediately or after 1 or 2 h
to FlAsH for an additional 30 min and then washed, fixed, and
examined under a fluorescence microscope. As shown in Fig.
6A, the existing pool of M protein, labeled red, was seen to be
localized to the plasma membrane, with some M protein
present inside the cytoplasm. The newly made M protein (labeled green) synthesized immediately after ReAsH labeling
was seen to be localized mostly in the cytoplasm, with a small
fraction detected at the plasma membrane (Fig. 6B). This
result indicates that newly synthesized M protein reaches the
plasma membrane less than 30 min after synthesis. Accumulation of the existing pool of M protein (labeled red) in the
plasma membrane continued to increase with time, with a
concomitant decrease in the cytoplasm (Fig. 6E and I). Data
from two similar but independent labeling studies suggested
that the existing pool of M protein shows a maximum plasma
membrane association within 2 1/2 h after synthesis (that is, at
2 h post-ReAsH labeling). The level of plasma membrane
association of newly synthesized M protein as well as the M
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FIG. 5. Plasma membrane association of the M protein is not affected by microtubule depolymerization. BHK-21 cells were left untreated (A,
B, and C) or treated with 10 g per ml of NOC (D, E, and F) for 3 h prior to infection with VSV-PeGFP-⌬M-Mtc at an MOI of 10. The cells
were incubated in medium lacking or containing NOC for 4 h. The infected cells were then treated with ReAsH for 30 min. After being washed,
the cells were fixed and examined for epifluorescence under a fluorescence confocal microscope. NOC (-), NOC-untreated cells; NOC (⫹),
NOC-treated cells. Merged PeGFP (A and D) and ReAsH (B and E) fluorescent images of cells are shown in the right panels (C and F).
(G) Quantitation of the amount of Mtc accumulated in the plasma membranes of infected cells in the presence (⫹) or absence (⫺) of NOC. Total
fluorescence intensities (in arbitrary units) were determined as described in Materials and Methods and then plotted as histograms, with error bars
indicating standard deviations. The P value for the difference was ⬎0.05.

protein synthesized post-ReAsH labeling also increased
steadily with time (Fig. 6F and J) and colocalized with the
already existing pool of M protein at the plasma membrane
(Fig. 6G and K). By 2 h post-ReAsH labeling, most of the
newly synthesized M protein (labeled green) was localized to
the plasma membrane (Fig. 6J and K), with a fraction of the
protein still in the cytoplasm. At this time point, both red and
green fluorescence showed maximum colocalization (Fig. 6K)

FIG. 6. Dynamic imaging of existing and newly synthesized pools of
M protein by dual biarsenical labeling. BHK-21 cells infected with
VSV-⌬M-Mtc were treated with ReAsH for 30 min at 4 hpi (A, E, and
I), washed, and then labeled immediately (A, B, C, and D) or 1 h (E,
F, G, and H) or 2 h (I, J, K, and L) later with FlAsH for 30 min (B, F,
and J). Following biarsenical dye labeling, the cells were washed, fixed,
immunostained with anti-M MAb and Alexa 350-conjugated secondary
antibody (D, H, and L), and examined by confocal fluorescence microscopy as described in Materials and Methods. Merged images of
cells stained with ReAsH and FlAsH are shown in panels C, G, and K.

as a result of accumulation of most of the M protein at the
plasma membrane. No further increase in the accumulation of
M protein in the plasma membrane was detected with increasing times after ReAsH labeling (data not shown). Overall,
these results indicate that the M protein reaches the plasma
membrane less than 30 min after synthesis, confirming previous observations (2) that the plasma membrane association of
the M protein is rapid and occurs less than 5 min after synthesis. Additionally, our data show that the M protein continues to
accumulate at the plasma membrane for 2 1/2 h after synthesis.
The specificities of the dyes to bind to the M proteins were
further confirmed by examining the immunostaining pattern of
M with anti-M MAb (Fig. 6D, H, and L), which closely overlapped with the red and green staining. A similar dynamic
distribution of the Mtc protein was also noted in cells ectopically expressing the protein (data not shown), indicating that
the membrane localization properties and intracellular distribution of the M protein were not influenced by the presence of
the viral NCs or other viral proteins.
Examination of virus uncoating in infected cells. We next
wanted to determine if attachment of the dually fluorescent
virus particles to the cell surface and subsequent entry and
uncoating of the particles in the cytoplasm can be visualized.
BHK-21 cells grown on a glass-bottomed culture dish were
infected at 4°C for 45 min with dually fluorescent virus particles to synchronize virus infection. Following washing of the
infected cells to remove the unadsorbed virus particles, multiple dually fluorescent (yellow) particles were seen attached to
the cellular plasma membrane when observed under a fluorescence microscope (data not shown). To determine the average
time it takes for virus particles to enter the cells, fuse with the
endosomes, and release the viral NCs into the cytoplasm, we
performed a time course experiment. We reasoned that the
intact virus particles in the cytoplasm would appear as yellow
dots when excited with both lasers simultaneously, while the
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FIG. 7. Uncoating of dually fluorescent virus particles in infected cells. BHK-21 cells on glass coverslips were treated with cycloheximide for
1 h and then infected with ReAsH-labeled VSV-PeGFP-⌬M-Mtc at 4°C. Following adsorption, the cells were washed and incubated in
cycloheximide-containing medium at 37°C. Coverslips were collected immediately or at various times after incubation, fixed with paraformaldehyde, and examined under a confocal fluorescence microscope. (a to f) Representative images of areas of cells immediately after or 10, 20, 30, 40,
and 50 min after incubation, showing the intact virions (yellow dots), some of which are identified by filled arrows, and the released NCs (green
dots), some of which are identified by open arrows. (g) Numbers of intact virions remaining in the cytoplasm at various times postadsorption. Error
bars show standard deviations from three independent experiments. The time taken for 50% of virions to have released their NCs (t1/2 of uncoating)
is shown.

PeGFP-containing virus NCs released into the cytoplasm
would appear as green dots due to the loss of the ReAsHlabeled Mtc-containing viral envelope. We also reasoned that
tracking of the input particles and the NCs would be unequivocal under conditions in which new NCs were not synthesized.
To carry out the study, BHK-21 cells on glass coverslips were
first treated with cycloheximide for 1 h to inhibit viral protein
synthesis and therefore block new NC synthesis. The cells were
then infected with the dually fluorescent particles at a multiplicity of infection (MOI) of 10. Virus adsorption was allowed
for 45 min at 4°C. Following adsorption, the cells were extensively washed with cold phosphate-buffered saline and incubated in medium at 37°C in the presence of cycloheximide.
Coverslips were collected immediately or at 10-min intervals
after incubation, and the cells were fixed and examined under
a confocal fluorescence microscope for detection of yellow
dots (intact virus particles) as well as green dots (released NCs)
in the cytoplasm. As shown in Fig. 7a, only intact virus particles
(yellow) were detected on the surfaces of the infected cells
immediately following virus adsorption. Ten min after adsorption, the number of yellow dots detected remained largely
unchanged. However, as the time of incubation increased,
smaller numbers of yellow dots could be detected in the cytoplasm, with concomitant increases in the number of green dots
(Fig. 7b to f). Counting about 20 to 25 infected cells and
approximately 8 to 12 yellow and green dots per cell, we found
that the majority of the virus particles (yellow dots) released
the NCs (green dots) into the cytoplasm between 20 min and
40 min after adsorption. We performed the experiment three
times and counted the number of virus particles remaining
intact at various times after adsorption. Our results (Fig. 7g)
showed that it takes approximately 28 min for 50% of virus
particles to uncoat their NCs and release them into the cytoplasm. Furthermore, we found that even after 60 min of incubation, nearly 10% of the particles still remained intact in the
cytoplasm.

Interestingly, we consistently observed that the number of
green dots gradually decreased 40 min after incubation and
that very few green dots could be detected after 60 min. The
reasons for this are unclear, but it is possible that the polymerase molecules (L and PeGFP complexes) associated with the
released NCs were coming off the N-RNA templates following
transcription.
DISCUSSION
In the present study, we described a strategy for generating
a dually fluorescent recombinant VSV. A VSV genome encoding PeGFP in place of wt P and Mtc in place of wt M allowed
recovery of infectious virus. Cells infected with this virus and
treated with the biarsenical red dye ReAsH produced progeny
virions that appeared green under a fluorescence microscope
due to incorporation of PeGFP and appeared red due to incorporation of ReAsH-labeled Mtc. This work describes for
the first time the recovery of infectious rhabdoviruses encoding
and incorporating a tagged M protein. Using VSV encoding
Mtc, we show by sequential labeling with the two biarsenical
dyes that newly synthesized M protein reaches the plasma
membrane within 30 min after synthesis. We further show that
the transport and plasma membrane localization of M protein
are not dependent on microtubules, which are generally used
for transport of macromolecules inside the cell. Additionally,
using the dually fluorescent virus, we show that following virus
adsorption, it takes approximately 28 min for one-half of the
virus particles to enter a cell and release the NCs into the
cytoplasm in a synchronized infection model.
In the past few years, the use of fluorescent proteins as tags
has been critical in understanding the dynamic events of virus
infection in living cells (for reviews, see references 8, 22, and
23). Using viruses genetically tagged with fluorescent proteins
or with envelopes labeled with lipophilic dyes, several aspects
of virus biology and virus-cell interactions have been examined.
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Fluorescent viruses have been used to study intracellular transport of viral capsids, capsid assembly, genome recombination,
virus entry and egress, gene expression, tissue tropism and
pathogenesis, and RNP transport and also for live tracking of
single particles in infected cells (7, 29, 33, 34, 40, 43, 50, 55).
For an enveloped virus such as VSV, which enters cells by
endocytosis, infection proceeds by fusion of the viral envelope
with the endosomal membrane, and subsequently, the NC is
released into the cytoplasm. To study the early events during
virus entry and the mechanisms of NC uncoating in the cytoplasm, dual-fluorescently labeled virus particles in which the
NC core is labeled with one fluorescent color and the viral
envelope is labeled with another fluorescent color would be
highly desirable. Therefore, we sought to generate a dually
fluorescent VSV where eGFP is fused in frame with the P
protein (component of the viral NC core) and mRFP is fused
in frame with the M protein (a component of the viral envelope). Multiple attempts to rescue such a virus failed, indicating that MmRFP protein with mRFP fused at the carboxy
terminus of the M protein is not competent to support production of infectious VSV. Recently, similar attempts to recover rabies virus encoding a fluorescently tagged M protein
were also unsuccessful (27). Likewise, Ebola virus VP40 (the
counterpart of matrix protein) fused with GFP also did
not support virus-like particle assembly (45). However, we
were successful in generating a recombinant VSV encoding
MmRFP as an extra cistron in the G-L intergenic junction (Fig.
1C). It should be noted that the fusion of mRFP to the M
protein at either the carboxy terminus or the amino terminus
retained the properties of M protein-like plasma membrane
association and transcription inhibition of VSV minireplicons
(S. C. Das, D. Panda, and A. K. Pattnaik, unpublished data),
yet the M fusion proteins were not incorporated into the progeny virions. On the other hand, the Mtc protein with a small
tag at the carboxy terminus of M faithfully recapitulated the
properties of M protein and supported the assembly of infectious virus. It is possible that the large size of the MmRFP
fusion protein interferes with the virus assembly functions of
the M protein. Since the viruses encoding MmRFP in an extra
cistron grew to reasonable titers (Fig. 1D), it appears that the
MmRFP fusion protein does not impart a trans-dominantnegative phenotype on the assembly functions of the wt M
protein.
The method of tc tagging and biarsenical dye labeling of
proteins in vivo was developed recently and holds promise to
overcome the size constraints of fluorescent protein tagging
(24, 38, 39). One significant advantage of the system is that the
tc hairpin can bind specifically and irreversibly to the biarsenical dyes immediately after synthesis, so the proteins can be
visualized by fluorescence microscopy. The biarsenical labeling
reagents can also be applied sequentially to label existing and
nascently synthesized pools of proteins differentially and thus
can allow for visualization of protein dynamics in living cells
(20, 38, 46, 48). Therefore, tc tagging of M protein and sequential labeling of M with both dyes offer significant advantages over conventional detection of M protein with anti-M
antibody staining. Using the two biarsenical dyes (ReAsH and
FlAsH) and a sequential labeling approach, we have found that
M reaches the plasma membrane within 30 min of synthesis
and continues to accumulate there for 2 1/2 hours after syn-
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thesis (Fig. 6). Previous biochemical and membrane fractionation studies have determined that plasma membrane association of the M protein is rapid and occurs less than 5 min after
synthesis (2). Although our data presented here are not as
precise as those in the previous study (2) due to the limitation
of the biarsenical dye labeling method, which requires incubation with the dye for at least 30 min, our approach has been
very useful in observing the protein dynamics of the existing
and newly synthesized pools of M protein.
Previous studies with VSV (11, 12, 26, 37), rabies virus (41),
parainfluenza virus (13), and measles virus (49) have suggested
that the matrix protein binds to NCs. Moreover, the M proteins of measles virus, parainfluenza virus, and Ebola virus
drive budding of progeny virions by specific interaction with
the viral NCs (13, 45, 49). In cells infected with VSV-PeGFP⌬M-Mtc and labeled with ReAsH, we were unable to observe
interaction of M protein with the viral NCs either inside the
cytoplasm or at the plasma membrane, consistent with previous reports (18, 54). It is possible that during virus assembly,
initial interaction of a limited number of M molecules (beyond
the limits of detection of fluorescence microscopy) with the
NCs at the plasma membrane renders the NCs assembly competent, which then recruits more M protein to the assembly
site. Thus, it appears that the mode of assembly of VSV might
be different from that of other enveloped viruses at the plasma
membrane.
The M protein of VSV is synthesized as a soluble fraction
inside the cytoplasm and is transported toward the plasma
membrane (2, 5, 12, 18). Early biochemical studies indicated
that the M protein associates with the plasma membrane independent of VSV G protein (5). However, the mode of transport of the M protein toward the plasma membrane is unclear.
Since the M protein has been shown to physically associate
with tubulin (42), we reasoned that the M protein could be
transported to the plasma membrane in a microtubule-dependent mechanism. However, our results (Fig. 5) suggest a microtubule-independent mechanism for the transport of the M
protein to the plasma membrane. Additionally, disruption of
actin filaments, another cytoskeletal structure, also did not
affect M protein transport (data not shown). Since we had
previously shown that the viral NCs are transported toward the
cell periphery in a microtubule-dependent manner (14), our
data presented here clearly support the idea that the M protein
and the NCs are transported toward the plasma membrane
independent of each other. Further work will be necessary to
determine the mode of transport of the M protein to the
plasma membrane.
During VSV infection, the M protein dissociates from other
viral components and is distributed throughout the cytoplasm
(47). However, the step at which the M protein dissociates
from the viral NCs is unclear. It has been demonstrated that
fusion of the viral envelope with the endosomal membrane and
the release of the NC into the cytoplasm are two independent
but successive steps in the endocytic pathway of VSV infection
(31). Release of viral NCs into the lumen of the endosomal
vesicle occurs by the fusion of the viral envelope with the
membranes of the endosomes. However, the NC release into
the cytoplasm may require a back-fusion event in which the
internal vesicles fuse with the membranes of the late endosome
(31). These studies have shown that fusion of the endosomal
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membrane with the viral envelope occurs approximately 20 to
25 min after virus entry (31). Using the dually fluorescent virus,
our observation that NCs are released from virus particles with
a half-life of uncoating of approximately 28 min suggests that
the back-fusion event which is necessary for the release of the
NCs into the cytoplasm following fusion of the viral envelope
with the membranes of the endosomes must be a fast process
requiring less than 10 min.
The potential use of the tc-tagged virus particles reported
here for studies on virus entry and uncoating as well as virus
assembly and egress in infected cells is exciting. The tc motif
can be processed after ReAsH labeling for both live-cell imaging and photoconversion of diaminobenzidine to allow direct
correlation of live-cell images with high-resolution electron
microscopic data (20, 21). Thus, VSV-PeGFP-⌬M-Mtc and
VSV-⌬M-Mtc viruses will be valuable tools in studies to understand the mechanisms of VSV assembly and the role of the
M protein in the process. The precise location of the M protein
inside the virion is unclear. Some studies suggest that the M
protein forms a bridge between the G protein and the viral NC
(11, 26, 36, 44), while other studies suggest that the M protein
forms a cigar-shaped scaffold around which the viral NC is
wrapped (3, 4). Since the ReAsH dye can be used for photoconversion of diaminobenzidine, which can allow direct correlation of live-cell images with electron microscopy (20, 21), the
ReAsH-labeled VSV-⌬M-Mtc viruses could be used to reexamine the internal organization of the M protein in purified VSV.
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